Closing Bell: Briacell Therapeutics Corp down on Thursday (BCT)

In trading today, shares of Briacell Therapeutics Corp opened at $1.33 and closed at $1.25. Intraday prices ranged from a low of $1.20 to a high of $1.33.

Share prices shrank -8.09% from the previous day's close of $1.36.

During the day across North America, the TSX Composite closed 0.87% at 22544.13, the S&P 500 closed 1.02% at 5633.91, the Dow Jones Industrial Average closed 1.09% at 39721.36 and the Nasdaq Composite closed 1.18% at 18647.45.

Briacell Therapeutics Corp traded under BCT on the Toronto Stock Exchange (TSX).

A total of 10,355 shares was traded during the session, with total trades of 65, while having an average volume of 7,073 over the last 5-days.

The TSX market on the whole today saw 4,281 price advancers against 982 declines and 87 unchanged.

During the prior 52 weeks, BCT.TO has traded as high as $10.29 (August 28,2023) and low as $1.20 (July 11,2024). Moreover, the shares have plummeted -85.47 percent in the last year, while they have plummeted -83.97% this year.

Following today's trading, Briacell Therapeutics Corp has a market capitalization of $24.87 million on a float of 18,285 shares outstanding. Its annual EPS is $-0.37.

Briacell Therapeutics Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Briacell Therapeutics Corp is holding an average recommendation of "Strong Buy" from 1.00 analysts according to Zacks. From those 1 analysts, 1 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..